Compare
Hyperfine, Inc. vs Escalon Medical Corp vs QT Imaging Holdings, Inc. vs Precision Optics Corporation, Inc.
| Latest fiscal year | Hyperfine, Inc. HYPR | Escalon Medical Corp ESMC | QT Imaging Holdings, Inc. QTI | Precision Optics Corporation, Inc. POCI |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-06-30 | 2025-12-31 | 2025-06-30 |
| Revenue | $13.56M | $12.05M | $18.93M | $19.09M |
| Revenue growth (YoY) | +5.2% | +0.5% | +287.9% | -0.1% |
| Gross margin | 49.8% | 45.7% (computed) | 45.4% | 17.8% |
| Operating margin | -273.4% | 1.1% | -23.4% | -29.1% |
| Net margin | -262.3% | 0.9% | -111.4% | -30.3% |
| Net income | -$35.57M | $105.5K | -$21.08M | -$5.78M |
| EPS (Diluted) | -$0.43 | $0.00 | -$2.01 | -$0.85 |
| Operating cash flow | -$27.95M | $380.7K | -$8.96M | -$3.55M |
| Free cash flow | -$29.13M | $376.8K | -$9.08M | -$3.77M |
| Cash & equivalents | $35.09M | $545.8K | $10.41M | $1.77M |
| Total assets | $55.26M | $4.99M | $23.02M | $19.79M |
| Total liabilities | $14.26M | $3.08M | $16.58M | $7.53M |
| Shareholders' equity | $41.01M | $1.92M | $6.45M | $12.26M |
| Return on year-end equity | -86.8% | 5.5% | -327.1% | -47.2% |
| Shares outstanding | n/a | 7.42M | 11.90M | 7.71M |
Revenue, most recent five fiscal years
| Fiscal year | Hyperfine, Inc. | Escalon Medical Corp | QT Imaging Holdings, Inc. | Precision Optics Corporation, Inc. |
|---|---|---|---|---|
| Latest | $13.56M Ended 2025-12-31 | $12.05M Ended 2025-06-30 | $18.93M Ended 2025-12-31 | $19.09M Ended 2025-06-30 |
| 1 year earlier | $12.89M Ended 2024-12-31 | $11.98M Ended 2024-06-30 | $4.88M Ended 2024-12-31 | $19.10M Ended 2024-06-30 |
| 2 years earlier | $11.03M Ended 2023-12-31 | $12.18M Ended 2023-06-30 | $40.4K Ended 2023-12-31 | $21.04M Ended 2023-06-30 |
| 3 years earlier | $6.81M Ended 2022-12-31 | $10.70M Ended 2022-06-30 | n/a | $15.68M Ended 2022-06-30 |
| 4 years earlier | $1.50M Ended 2021-12-31 | $10.47M Ended 2021-06-30 | n/a | $10.67M Ended 2021-06-30 |